Retroviral ADA-transduced CD34+ cells (NHGRI/UCLA)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRetroviral ADA-transduced CD34+ cells (NHGRI/UCLA)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionAnti-CD34
TargetsHematopoietic progenitor cell antigen CD34
Therapy Area/IndicationsAdenosine deaminase deficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUcla Biomedical Library
China Registration ClassN/A

Develop Information

Active CompaniesUcla Biomedical Library
Inactive CompaniesN/A
Active IndicationsAdenosine deaminase deficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A